Montreal, Canada

Ginette McKercher

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim (Canada) Ltd.. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ginette McKercher

Introduction

Ginette McKercher is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of methods for identifying inhibitors of HCV polymerase. Her work is crucial in the ongoing fight against hepatitis C, a virus that affects millions worldwide.

Latest Patents

Ginette holds a patent for a "Direct binding assay for identifying inhibitors of HCV polymerase." This innovative method involves contacting HCV polymerase or an analog thereof with a specific probe formula. The patent outlines the steps necessary to identify compounds that bind to HCV polymerase, showcasing her expertise in the field.

Career Highlights

Ginette is currently employed at Boehringer Ingelheim (Canada) Ltd., where she continues to advance her research and development efforts. Her work at this esteemed company allows her to collaborate with other talented professionals in the industry.

Collaborations

Throughout her career, Ginette has worked alongside notable colleagues such as Pierre Louis Beaulieu and George Kukolj. These collaborations have further enriched her research and contributed to the success of her projects.

Conclusion

Ginette McKercher's innovative work in biotechnology and her patent for identifying inhibitors of HCV polymerase highlight her significant contributions to the field. Her ongoing efforts at Boehringer Ingelheim (Canada) Ltd. continue to pave the way for advancements in medical research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…